LMR Partners’s Argos Therapeutics ARGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-2,251
Closed -$16K – 692
2017
Q2
$16K Buy
+2,251
New +$19.2K ﹤0.01% 592

Other funds holding ARGS

LMR Partners's ARGS Position: Q3 2017 in Review

LMR Partners sold out of Argos Therapeutics (ARGS) in Q3 2017, closing a stake of 2,251 shares — an estimated $16K sold.

LMR Partners first reported a position in ARGS in Q2 2017 and held it in 1 quarter. The position peaked at $16K in Q2 2017. 29 funds tracked by Wall St. Rank hold ARGS as of Q3 2017.

  • LMR Partners reported no remaining Argos Therapeutics position as of Q3 2017 after selling out during the quarter.
  • LMR Partners sold 2,251 Argos Therapeutics shares in Q3 2017, an estimated $16K.
  • LMR Partners first reported a position in Argos Therapeutics in Q2 2017 and held it in 1 quarter.
  • LMR Partners's Argos Therapeutics position peaked at $16K in Q2 2017.
  • 29 funds tracked by Wall St. Rank held Argos Therapeutics as of Q3 2017.

Based on LMR Partners's 13F filing for Q3 2017, filed 9 Nov 2017.